Adropin appears to exert a protective effect on the endothelium and cardiac myocytes and has been suggested as a biomarker of endothelial dysfunction, adverse cardiac remodeling, renal failure, and HF [28,29,30]. Here, ENHO is linked to hydrops fetalis.